KLK2
Basic information
Region (hg38): 19:50861568-50880567
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the KLK2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 13 | 16 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 13 | 3 | 0 |
Variants in KLK2
This is a list of pathogenic ClinVar variants found in the KLK2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-50874737-C-G | not specified | Uncertain significance (Jun 13, 2024) | ||
19-50874745-G-A | not specified | Uncertain significance (Jan 10, 2023) | ||
19-50874773-G-T | not specified | Uncertain significance (Aug 12, 2021) | ||
19-50874775-A-G | not specified | Uncertain significance (Dec 08, 2023) | ||
19-50874795-G-A | not specified | Uncertain significance (Mar 15, 2024) | ||
19-50874819-C-A | not specified | Uncertain significance (Aug 08, 2023) | ||
19-50874837-G-C | not specified | Uncertain significance (Nov 10, 2022) | ||
19-50876491-G-A | not specified | Uncertain significance (Oct 10, 2023) | ||
19-50876557-C-T | not specified | Uncertain significance (Oct 27, 2022) | ||
19-50876576-G-A | not specified | Uncertain significance (Nov 09, 2023) | ||
19-50876589-T-A | not specified | Uncertain significance (Apr 17, 2023) | ||
19-50876738-G-A | not specified | Uncertain significance (Apr 17, 2024) | ||
19-50876878-G-A | not specified | Uncertain significance (Jul 13, 2021) | ||
19-50876884-G-A | not specified | Likely benign (Dec 20, 2021) | ||
19-50876916-T-C | not specified | Likely benign (Aug 04, 2023) | ||
19-50876920-A-G | not specified | Uncertain significance (Dec 03, 2021) | ||
19-50878425-G-A | not specified | Likely benign (Mar 12, 2024) | ||
19-50878491-C-T | not specified | Uncertain significance (Nov 08, 2022) | ||
19-50878508-G-C | not specified | Uncertain significance (Dec 15, 2023) | ||
19-50878521-C-T | Acute myeloid leukemia | Benign (Jul 22, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
KLK2 | protein_coding | protein_coding | ENST00000325321 | 5 | 19000 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000128 | 0.645 | 125699 | 0 | 48 | 125747 | 0.000191 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.117 | 143 | 147 | 0.973 | 0.00000747 | 1690 |
Missense in Polyphen | 42 | 49.289 | 0.85212 | 612 | ||
Synonymous | 0.762 | 50 | 57.3 | 0.872 | 0.00000295 | 527 |
Loss of Function | 0.782 | 7 | 9.62 | 0.728 | 4.10e-7 | 111 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000580 | 0.0000580 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000764 | 0.000761 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.000247 | 0.000246 |
Middle Eastern | 0.000764 | 0.000761 |
South Asian | 0.0000655 | 0.0000653 |
Other | 0.000326 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Glandular kallikreins cleave Met-Lys and Arg-Ser bonds in kininogen to release Lys-bradykinin.;
- Pathway
- Renin-angiotensin system - Homo sapiens (human);Endocrine and other factor-regulated calcium reabsorption - Homo sapiens (human);Androgen Receptor Network in Prostate Cancer;Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3;Signal Transduction;Metabolism of proteins;Extracellular matrix organization;Activation of Matrix Metalloproteinases;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3;RHO GTPases activate PKNs;RHO GTPase Effectors;Signaling by Rho GTPases;Coregulation of Androgen receptor activity;Degradation of the extracellular matrix;Regulation of Androgen receptor activity
(Consensus)
Intolerance Scores
- loftool
- 0.281
- rvis_EVS
- 0.55
- rvis_percentile_EVS
- 81.48
Haploinsufficiency Scores
- pHI
- 0.0786
- hipred
- N
- hipred_score
- 0.166
- ghis
- 0.436
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0320
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- regulation of systemic arterial blood pressure;extracellular matrix disassembly;zymogen activation
- Cellular component
- extracellular region;secretory granule;extracellular exosome
- Molecular function
- serine-type endopeptidase activity